Vertex Pharmaceuticals
VRTX
$317.27
Share price
-1.80%
Change (1 day)
29.15%
Change (1 year)
Categories
EPS for Vertex Pharmaceuticals (VRTX)
EPS in 2022 (TTM): $12.81
According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $12.81. In 2021 the company made an earnings per share (EPS) of $9.10 a decrease over its 2020 EPS that were of $10.42.
EPS history for Vertex Pharmaceuticals from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | $12.81 | 40.77% |
| 2021 | $9.10 | -12.67% |
| 2020 | $10.42 | 128.01% |
| 2019 | $4.57 | -44.54% |
| 2018 | $8.24 | 670.09% |
| 2017 | $1.07 | -327.66% |
| 2016 | -$0.47 | -79.65% |
| 2015 | -$2.31 | -26.43% |
| 2014 | -$3.14 | 53.92% |
| 2013 | -$2.04 | 316.33% |
| 2012 | -$0.49 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $7.28 | -43.15% | 🇺🇸 USA |
 AbbVie ABBV | $7.58 | -40.80% | 🇺🇸 USA |
 Gilead Sciences GILD | $2.66 | -79.23% | 🇺🇸 USA |
 Merck MRK | $6.03 | -52.93% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.12 | -75.63% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | -$5.86 | -145.75% | 🇺🇸 USA |